These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Effects of the competitive NMDA receptor antagonist, CGP 37849, on anticonvulsant activity and adverse effects of valproate in amygdala-kindled rats. Löscher W, Hönack D. Eur J Pharmacol; 1993 Apr 06; 234(2-3):237-45. PubMed ID: 8097722 [Abstract] [Full Text] [Related]
5. Electrical but not chemical kindling increases sensitivity to some phencyclidine-like behavioral effects induced by the competitive NMDA receptor antagonist D-CPPene in rats. Wlaź P, Ebert U, Potschka H, Löscher W. Eur J Pharmacol; 1998 Jul 24; 353(2-3):177-89. PubMed ID: 9726648 [Abstract] [Full Text] [Related]
6. Anticonvulsant effects of dextrorphan in rats: possible involvement in dextromethorphan-induced seizure protection. Tortella FC, Ferkany JW, Pontecorvo MJ. Life Sci; 1988 Jul 24; 42(24):2509-14. PubMed ID: 3374269 [Abstract] [Full Text] [Related]
7. Dextromethorphan, a common antitussive, reduces kindled amygdala seizures in the rat. Feeser HR, Kadis JL, Prince DA. Neurosci Lett; 1988 Apr 12; 86(3):340-5. PubMed ID: 3380326 [Abstract] [Full Text] [Related]
9. Anticonvulsant and behavioral effects of two novel competitive N-methyl-D-aspartic acid receptor antagonists, CGP 37849 and CGP 39551, in the kindling model of epilepsy. Comparison with MK-801 and carbamazepine. Löscher W, Hönack D. J Pharmacol Exp Ther; 1991 Feb 12; 256(2):432-40. PubMed ID: 1671593 [Abstract] [Full Text] [Related]
11. Kindled rats are more sensitive than non-kindled rats to the behavioural effects of combined treatment with MK-801 and valproate. Dziki M, Hönack D, Löscher W. Eur J Pharmacol; 1992 Nov 10; 222(2-3):273-8. PubMed ID: 1360405 [Abstract] [Full Text] [Related]
13. Effects of dextromethorphan, a nonopioid antitussive, on development and expression of amygdaloid kindled seizures. Takazawa A, Anderson P, Abraham WC. Epilepsia; 1990 Nov 10; 31(5):496-502. PubMed ID: 2401241 [Abstract] [Full Text] [Related]
15. Low doses of NMDA receptor antagonists synergistically increase the anticonvulsant effect of the AMPA receptor antagonist NBQX in the kindling model of epilepsy. Löscher W, Rundfeldt C, Hönack D. Eur J Neurosci; 1993 Nov 01; 5(11):1545-50. PubMed ID: 7904524 [Abstract] [Full Text] [Related]
19. The effect of the non-NMDA receptor antagonist GYKI 52466 and NBQX and the competitive NMDA receptor antagonist D-CPPene on the development of amygdala kindling and on amygdala-kindled seizures. Dürmüller N, Craggs M, Meldrum BS. Epilepsy Res; 1994 Feb 01; 17(2):167-74. PubMed ID: 8194512 [Abstract] [Full Text] [Related]
20. Pharmacological profile of dextrorphan. Fossati A, Vimercati MG, Caputo R, Valenti M. Arzneimittelforschung; 1995 Nov 01; 45(11):1188-93. PubMed ID: 8929237 [Abstract] [Full Text] [Related] Page: [Next] [New Search]